COMMUNIQUÉS West-GlobeNewswire

VALNEVA Reports Positive Initial Booster Data and Final Phase 1 Data for its Lyme Disease Vaccine Candidate

31/01/2019 - 07:02

Valneva Reports Positive Initial Booster Data and Final Phase 1 Data for its Lyme Disease Vaccine Candidate Saint-Herblain (France), January 31, 2019 - Valneva SE ("Valneva"), a biotech company developing and [...]

VALNEVA : résultats positifs pour la première évaluation de la dose de rappel du vaccin contre la maladie de Lyme et les données finales de l'étude de Phase 1

31/01/2019 - 07:02

Valneva : résultats positifs pour la première évaluation de la dose de rappel du vaccin contre la maladie de Lyme et les données finales de l'étude de Phase 1 Saint-Herblain (France), 31 janvier 2019 - Valneva SE (" [...]

Novan Provides Business Update

30/01/2019 - 22:15

End-of-Phase 2 meeting with FDA for molluscum granted and scheduled for early March Active business development discussions ongoing around certain late-stage assets and broader dermatology platform Dr. David Hebert [...]

aTyr Pharma Announces Research Collaboration with the University of Nebraska Medical Center and Expansion of Successful Pilot Study

30/01/2019 - 22:00

Collaboration to advance neuropilin-2 biology and explore potential therapeutic opportunities for ATYR1923 Reinforces aTyr’s commitment to working with a strategic network of leading academic collaborators SAN DIEGO, [...]

Major shareholder announcement

30/01/2019 - 19:48

Orphazyme A/S Company announcement No. 02/2019 Company Registration No. 32266355 Copenhagen, January 30, 2019 – Orphazyme A/S, a biopharmaceutical company dedicated to developing treatments for patients living with rare [...]

Genesis HealthCare Recognized as a We Honor Veterans Community Partner

30/01/2019 - 19:29

KENNETT SQUARE, Pa., Jan. 30, 2019 (GLOBE NEWSWIRE) -- Veterans often carry experiences from their military service that present unique healthcare challenges, and unfortunately, many of them may not know about, or have [...]

DLT Resolution Divests A.J.D Data, Strengthens Balance Sheet and Expands Secure Data Services

30/01/2019 - 18:53

Las Vegas, NV, Jan. 30, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- DLT Resolution Inc. (OTC: DLTI), a Distributed Ledger Technology (“Blockchain”) Data Management and Information Technology company, is pleased to [...]

Is Too Much Exercise Dangerous?

30/01/2019 - 18:05

Study shows that extreme exercise does not increase risk of death from heart disease DALLAS, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Athletes come in all forms, from the professional athlete to the everyday runner. We know [...]

Sienna Announces Fourth Quarter 2018 Results Release Date and Conference Call - Date Change

30/01/2019 - 18:00

MARKHAM, Ontario, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (" Sienna " or the " Company ") (TSX: SIA) announced that it has moved up the date for when it will report its 2018 fourth quarter results. [...]

Medtronic Valiant(TM) Captivia(TM) Demonstrates Durability, Safety, and Efficacy at Five Years in Transection Patients

30/01/2019 - 16:31

New RESCUE Trial Data Presented in Blunt Thoracic Aortic Injury DUBLIN and SAN DIEGO - January 30, 2019 - Medtronic plc (NYSE:MDT) today announced new data supporting the long-term durability, safety, and efficacy of [...]

HEXO Corp. closes C$57.5 million public offering of common shares

30/01/2019 - 15:25

GATINEAU, Quebec, Jan. 30, 2019 (GLOBE NEWSWIRE) -- HEXO Corp. (“HEXO” or the “Company”) (TSX: HEXO ; NYSE-A: HEXO ) is pleased to announce the closing of its previously announced marketed offering of 8,855,000 common [...]

HEXO Corp annonce la clôture de son offre publique d’actions ordinaires de 57,5 M $ CA

30/01/2019 - 15:25

GATINEAU, Québec, 30 janv. 2019 (GLOBE NEWSWIRE) -- HEXO Corp (« HEXO » ou la « Société ») (TSX: HEXO ; NYSE-A: HEXO ) a le plaisir d’annoncer la clôture de son placement négocié annoncé précédemment de 8 855 000 [...]

Eve & Co Announces German Supply Agreement

30/01/2019 - 15:15

TORONTO, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (the “Company” or “Eve & Co”) (TSXV: EVE; OTCQB: EEVVF) is pleased to announce that its wholly-owned subsidiary Natural MedCo Ltd. has entered [...]

Sanofi: Fexinidazole, the first all-oral treatment for sleeping sickness, approved in Democratic Republic of Congo

30/01/2019 - 15:01

Fexinidazole will contribute to international efforts to eliminate sleeping sickness, a fatal neglected tropical disease endemic to Africa, by 2020 It is the first all-oral treatment for sleeping sickness, and is [...]

Sanofi : Le fexinidazole, premier traitement entièrement par voie orale contre la maladie du sommeil, approuvé en République Démocratique du Congo

30/01/2019 - 15:01

Le fexinidazole contribuera aux efforts déployés à l'échelle internationale en vue d'éliminer la maladie du sommeil - une maladie tropicale négligée, fatale et endémique en Afrique - à l'horizon 2020 Premier médicament [...]

Imprivata to Showcase Purpose-built Solutions for Healthcare at 2019 HIMSS Annual Conference

30/01/2019 - 15:00

Imprivata streamlines clinical workflows by offering ubiquitous access and multifactor authentication solutions LEXINGTON, Mass., Jan. 30, 2019 (GLOBE NEWSWIRE) -- Imprivata® , the healthcare IT security company, will [...]

CherryCircle Software Raises $2.3M to Advance QbDVision™ for Pharmaceutical Industry

30/01/2019 - 15:00

AUSTIN, Texas, Jan. 30, 2019 (GLOBE NEWSWIRE) -- CherryCircle Software, a company developing novel solutions for pharmaceutical process development, announced the closing of a $2.3 million Seed financing round. The [...]

Relievant Announces Level I INTRACEPT Study Enrollment Stopped Early for Superiority

30/01/2019 - 15:00

Intracept ® Procedure Demonstrates Highly Significant Treatment Effect vs. Non-Surgical Management MINNEAPOLIS, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately-held medical device company, developing [...]

NewLink Genetics to Participate in the Immuno-Oncology 360° Conference

30/01/2019 - 15:00

AMES, Iowa, Jan. 30, 2019 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) announced today that the Company’s Chairman, CEO and Chief Scientific Officer, Charles J. Link, Jr, MD, will participate in the [...]